NMC Health Plc Notice of General Meeting (8105T)
November 19 2019 - 1:01AM
UK Regulatory
TIDMNMC
RNS Number : 8105T
NMC Health Plc
19 November 2019
19 November 2019
NMC Health plc
(the "Company" or "NMC")
Proposed Share Buyback and Directors' Remuneration Policy -
Notice of General Meeting
NMC Health plc ("NMC" or the "Company") announces that it will
today be posting a circular to shareholders (the "Circular")
convening a general meeting to consider:
-- a general authority to make market purchases of NMC shares in
line with the Company's intention announced on 22 August 2019;
and
-- a proposed directors' remuneration policy, which the Company
is required to adopt in place of its existing policy, which was
previously approved in December 2016.
Copies of the Circular, including the notice of general meeting
to be held at 11.00am on 5 December 2019 at the offices of Allen
& Overy LLP, One Bishops Square, London E1 6AD, United Kingdom,
will be available on the Company's website
(https://nmc.ae/investorrelations/shareholderinformation).
A letter from the Joint Chairmen of the Company, and from the
Chairman of the Remuneration Committee, and the expected timetable
of principal events are also contained in the Circular.
A copy of the Circular has been submitted to the National
Storage Mechanism and will shortly be available for inspection at
www.morningstar.co.uk/uk/nsm.
For further enquiries, please contact:
NMC
Simon Watkins, Group Company Secretary +44 203 205 7313
Asjad Yahya, Investor Relations +971 (0)56 219 0975
Media
FTI Consulting, London
Brett Pollard / Victoria Foster Mitchell +44 (0)20 3727 1000
FTI Consulting, Gulf
Shane Dolan +971 (0)4 437 2100
About NMC Health
NMC is the leading private healthcare operator in the GCC with
an international network of healthcare facilities across 19
countries. NMC ranks as one of the top two in-vitro fertilisation
("IVF") operators globally. The Group is recognised as a leading
provider of long-term medical care in the UAE through its
subsidiary ProVita. Pursing a selective international expansion
program since 2016, the company now has total capacity of 3,109
beds across its network with 48% of this capacity in the Kingdom of
Saudi Arabia (KSA), where the company has introduced long-term and
multi-specialty care services. Moreover, the recent formation of a
joint venture with GOSI/Hassana Investment Company provides a solid
platform for continued growth in the GCC region's largest
healthcare market. NMC treated over 7.5m patients in 2018. The
Group is also a leading UAE supplier of products and consumables
across several key market segments, with the major contribution
coming from healthcare related products. The Group reported
revenues of US$2.1 billion for the year ended 31 December 2018.
In April 2012 NMC was listed on the Premium Segment of the
London Stock Exchange. NMC is a constituent of the FTSE 100
Index.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NOGEAXFPFSSNFFF
(END) Dow Jones Newswires
November 19, 2019 02:01 ET (07:01 GMT)
Nmc Health (LSE:NMC)
Historical Stock Chart
From Apr 2024 to May 2024
Nmc Health (LSE:NMC)
Historical Stock Chart
From May 2023 to May 2024